CMTM8
CKLF-like MARVEL transmembrane domain-containing protein 8
Also known as: CKLF8_HUMAN, CKLFSF8
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IZV2
- Gene
- CMTM8
- Ensembl
- ENSG00000170293
- Chromosome
- 3
- Canonical length
- 173 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene belongs to the chemokine-like factor gene superfamily, a novel family that is similar to the chemokine and the transmembrane 4 superfamilies. This gene is one of several chemokine-like factor genes located in a cluster on chromosome 3. This gene acts as a tumor suppressor, and plays a role in regulating the migration of tumor cells. The encoded protein is thought to function as a a negative regulator of epidermal growth factor-induced signaling. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
173 residues, UniProt reviewed canonical sequence.
>Q8IZV2|CMTM8
1 MEEPQRARSH TVTTTASSFA ENFSTSSSSF AYDREFLRTL PGFLIVAEIV LGLLVWTLIA
61 GTEYFRVPAF GWVMFVAVFY WVLTVFFLII YITMTYTRIP QVPWTTVGLC FNGSAFVLYL
121 SAAVVDASSV SPERDSHNFN SWAASSFFAF LVTICYAGNT YFSFIAWRSR TIQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CMTM8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 45 nTPM
- liver: 39 nTPM
- salivary gland: 19 nTPM
- lung: 17 nTPM
- epididymis: 16 nTPM
- placenta: 16 nTPM
Single-cell type
- breast lactating cells: 384 nCPM
- salivary ionocytes: 352 nCPM
- medullary thymic epithelial cells: 300 nCPM
- pancreatic acinar cells: 262 nCPM
- respiratory ionocytes: 236 nCPM
- cytotrophoblasts: 231 nCPM
Immune cell
- eosinophil: 1.6 nTPM
- memory CD4 T-cell: 0.9 nTPM
- naive CD4 T-cell: 0.6 nTPM
- memory CD8 T-cell: 0.2 nTPM
- gdT-cell: 0.1 nTPM
- MAIT T-cell: 0.1 nTPM
Brain region
- thalamus: 9.4 nTPM
- pons: 8 nTPM
- choroid plexus: 7.4 nTPM
- amygdala: 7.3 nTPM
- medulla oblongata: 7.3 nTPM
- basal ganglia: 7.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0.06
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CMTM8 as an antibody target. Whether an autoantibody or antibody against CMTM8 could matter depends on whether native CMTM8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CMTM8 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CMTM8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...